Octagon Capital Advisors LP
Q3 2025 13F Holdings
- Locationnew york, NY
- Num holdings
27
- Value ($000)
$659,758
- Date Filed 11/14/2025
- Form type13F-HR
- CIK 0001839435
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ABIVAX SA | SPONSORED ADS | 00370M103 | $112.49M | 17 % | 1,325,000 | ||
D DIANTHUS THERAPEUTICS INC | COM | 252828108 | $95.10M | 14 % | 2,416,667 | ||
G GOSSAMER BIO INC | COM | 38341P102 | $44.84M | 7 % | 17,050,000 | ||
C COGENT BIOSCIENCES INC | COM | 19240Q201 | $41.27M | 6 % | 2,874,111 | ||
A ARRIVENT BIOPHARMA INC | COM | 04272N102 | $36.37M | 6 % | 1,971,054 | ||
O OCULAR THERAPEUTIX INC | COM | 67576A100 | $30.67M | 5 % | 2,624,000 | ||
T TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | $29.65M | 5 % | 9,067,500 | ||
MERUS N V | COM | N5749R100 | $29.00M | 4 % | 308,000 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | $25.76M | 4 % | 2,815,000 | ||
M MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | $25.11M | 4 % | 2,130,000 |
Rows Per Page
10
- 10
- 50
- 100